-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 16, Buchang Pharmaceutical issued an announcement stating that, based on the current actual operating conditions and follow-up business development plans, the company decided to optimize resource allocation and organizational structure, reduce management costs, and improve operational management efficiency.
The cancellation does not involve related party transactions, nor does it constitute a major asset reorganization as stipulated in the "Administrative Measures for Major Asset Restructuring of Listed Companies", which does not need to be submitted to the board of directors or the general meeting of shareholders for approval
The above matters have been completed, and the company has recently received the "Notice of Deregistration of Foreign-invested Enterprises" issued by Xianyang Market Supervision and Administration Bureau